Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review)

xlomafota13 shared this article with you from Inoreader Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review) Via Experimental and therapeutic medicine Exp Ther Med. 2021 Dec;22(6):1479. doi: 10.3892/etm.2021.10914. Epub 2021 Oct 25. ABSTRACT Neuroendocrine neoplasms (NENs) are a heterogeneous group of rare tumors with different types of physiology and prognosis. Therefore, prognostic information, including morphological differentiation, grade, tumor stage and primary location, are invaluable and contribute to the formulation of treatment decisions. Biomarkers that are currently used, including chromogranin A (CgA), serotonin and neuron-specific enolase, are singular parameters that cannot be used to accurately predict variables associated with tumor growth, including proliferation, metabolic rate and metastatic potential. In addition, site-specific biomarkers, such as insulin and gastrin, cannot be applied to all types of NENs. The clinical application of broad-spectrum markers, as it is the case for CgA, remains controversial despite being widely used. Due to limitations of the curr ently available mono-analyte biomarkers, recent studies were conducted to explore novel parameters for NEN diagnosis, prognosis, therapy stratification and evaluation of treatment response. Identification of prognostic factors for predicting NEN outcome is a critical requirement for the planning of adequate clinical management. Advances in 'liquid' biopsies and genomic analysis techniques, including microRNA, circulating tumor DNA or circulating tumor cells and sophisticated biomathematical analysis techniques, such as NETest or molecular image-based biomarkers, are currently under investigation as potentially novel tools for the management of NENs in the future. Despite these recent findings yielding promising observations, further research is necessary. The present review therefore summarizes the existing knowledge and recent advancements in the exploration of biochemical markers for NENs, with focus on gastroenteropancreatic-neuroendocrine tumors. PMID:34765020 | PMC:PMC8576627 | DOI:10.3892/etm.2021.10914 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.